XTL Biopharmaceuticals Ltd. ADR (XTLB)
NASDAQ: XTLBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
XTLB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.87M
- EPS (TTM)
- -$0.36
- Dividend yield
- None
- 52-week range
- 1.98 – 7.44
- Day range
- 1.98 – 2.05
- Volume / Avg
- 27.80K / 8.18K
- Beta
- —
- Shares outstanding
- 2.46M
52-week range
XTLB stock today
Shares of XTL Biopharmaceuticals (XTLB) finished lower on Oct 7 at $1.98, a drop of 1.98% or $0.04 per share, versus the S&P 500's 0.22% decline. Volume was 3.4x the average at 27.80K shares, a sign of unusually heavy trading. At this level, XTLB sits near the bottom of its 52-week range of $1.98 to $7.44: 73.4% below the high and 0.3% above the low.
XTL Biopharmaceuticals has posted a net loss over the last twelve months (EPS of -$0.36), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About XTL Biopharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
XTL Biopharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LNAILunai Bioworks Inc. | 1.09 | -3.54% | $4.94M | vs XTLB |
| PPCBPropanc Biopharma Inc. | 0.4987 | +1.51% | $4.90M | vs XTLB |
| XBIOXenetic Biosciences Inc. | 2.21 | +2.55% | $5.18M | vs XTLB |
| NCNANuCana plc ADR | 1.14 | +4.59% | $4.74M | vs XTLB |
| PULMPulmatrix Inc. | 1.49 | +4.20% | $5.44M | vs XTLB |
| ADXNAddex Therapeutics Ltd ADR | 3.13 | -0.32% | $5.49M | vs XTLB |
| DRMADermata Therapeutics Inc. | 1.12 | -0.89% | $5.55M | vs XTLB |
| BGMSBio Green Med Solution Inc. | 0.85 | -0.67% | $5.63M | vs XTLB |
Indexes, lists and sector
XTL Biopharmaceuticals stock FAQ
What is XTL Biopharmaceuticals's stock price today?
XTLB last traded at $1.98 as of Oct 7, 4:00 PM EDT, down 1.98% on the day. Prices are delayed at least 15 minutes.
What is the XTLB 52-week high?
The 52-week high for XTLB is $7.44 and the 52-week low is $1.98. The stock is currently 73.4% below its high.